Our customers and patients trust us to deliver highest quality standards and we are committed to live up to this expectation.
We have a robust QMS system, with harmonized procedures and processes.All our products are manufactured in strict compliance with cGMP’s (current good manufacturing practices) and with strict adherence to the specifications approved by FDA.
All supply partners of Creekwood undergo a formal and rigorous assessment, qualification and monitoring process. This includes initial and periodic audits of facilities and quality management systems performed by our QA team.
Strength | 120 mg |
NDC | 82619-102-01 |
GTN | 382619102017 |
OTC/Rx | RX |
TE Code | BX |
Ref Brand | FENOGLIDE |
Therapeutic Class | Primary Hypercholesterolemia, Hypertriglyceridemia |
Strength | 40 mg |
NDC | 82619-101-01 |
GTN | 382619101010 |
OTC/Rx | RX |
TE Code | BX |
Ref Brand | FENOGLIDE |
Therapeutic Class | Primary Hypercholesterolemia, Hypertriglyceridemia |
Product Details | 12's Pack | 18's Pack |
---|---|---|
Strength | 10 mg | 10 mg |
NDC | 82619-112-04 | 82619-112-05 |
GTN | 382619112047 | 382619112054 |
OTC/Rx | RX | RX |
TE Code | AB | AB |
Ref Brand | MAXALT | MAXALT |
Therapeutic Class | Antimigraine | Antimigraine |
Product Details | 12's Pack | 18's Pack |
---|---|---|
Strength | 5 mg | 5 mg |
NDC | 82619-111-04 | 82619-111-05 |
GTN | 382619111040 | 382619111057 |
OTC/Rx | RX | RX |
TE Code | AB | AB |
Ref Brand | MAXALT | MAXALT |
Therapeutic Class | Antimigraine | Antimigraine |
Strength | 8 mg |
NDC | 82619-114-02 |
GTN | 382619114027 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | RAPAFLO |
Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
Strength | 8 mg |
NDC | 82619-114-01 |
GTN | 382619114010 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | RAPAFLO |
Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
Strength | 4 mg |
NDC | 82619-113-01 |
GTN | 382619113013 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | RAPAFLO |
Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
Strength | 1.25 mg+ 2.5 mg |
NDC | 82619-104-01 |
GTN | 382629104011 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | Covaryx |
Therapeutic Class | Hormone |
Strength | 0.625 mg + 1.25 mg |
NDC | 82619-103-01 |
GTN | 382619103014 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | Covaryx |
Case Qty | 12 |
Therapeutic Class | Hormone |